{
    "organizations": [],
    "uuid": "da9d2abc35626f2c980b064e93ad68131730e21d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-five-prime-therapeutics-appointed/brief-five-prime-therapeutics-appointed-linda-rubinstein-as-interim-cfo-idUSFWN1RU19Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Five Prime Therapeutics Appointed Linda Rubinstein As Interim CFO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - Five Prime Therapeutics Inc:\n* FIVE PRIME THERAPEUTICS INC - ON APRIL 13 APPOINTED LINDA RUBINSTEIN AS INTERIM CHIEF FINANCIAL OFFICER - SEC FILING\n* FIVE PRIME THERAPEUTICS INC - LINDA RUBINSTEIN, IS A PARTNER AT FLG PARTNERS, A CHIEF FINANCIAL OFFICER SERVICES AND BOARD ADVISORY CONSULTING FIRM Source text ( bit.ly/2H9a1Fw ) Further company coverage:\n ",
    "published": "2018-04-18T04:39:00.000+03:00",
    "crawled": "2018-04-18T18:04:59.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "five",
        "prime",
        "therapeutic",
        "inc",
        "five",
        "prime",
        "therapeutic",
        "inc",
        "april",
        "appointed",
        "linda",
        "rubinstein",
        "interim",
        "chief",
        "financial",
        "officer",
        "sec",
        "filing",
        "five",
        "prime",
        "therapeutic",
        "inc",
        "linda",
        "rubinstein",
        "partner",
        "flg",
        "partner",
        "chief",
        "financial",
        "officer",
        "service",
        "board",
        "advisory",
        "consulting",
        "firm",
        "source",
        "text",
        "company",
        "coverage"
    ]
}